Cosmo Bio Company,Limited (3386.T)
JPY 1129.0
(0.62%)
JPY 1129.0
(0.62%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 519 Million JPY | -36.4% |
| 2022 | 816 Million JPY | -22.14% |
| 2021 | 1.04 Billion JPY | 39.36% |
| 2020 | 752 Million JPY | 85.22% |
| 2019 | 406 Million JPY | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q1 | 305 Million JPY | 323.61% |
| 2024 Q2 | 18 Million JPY | -94.1% |
| 2023 Q1 | 400 Million JPY | 250.88% |
| 2023 Q3 | -11 Million JPY | -118.97% |
| 2023 FY | 519 Million JPY | -36.4% |
| 2023 Q4 | 72 Million JPY | 754.55% |
| 2023 Q2 | 58 Million JPY | -85.5% |
| 2022 Q3 | 76 Million JPY | 0.0% |
| 2022 FY | 816 Million JPY | -22.14% |
| 2022 Q4 | 114 Million JPY | 50.0% |
| 2021 FY | 1.04 Billion JPY | 39.36% |
| 2020 FY | 752 Million JPY | 85.22% |
| 2019 FY | 406 Million JPY | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Shin Nippon Biomedical Laboratories, Ltd. | 4.16 Billion JPY | 87.531% |
| DNA Chip Research Inc. | -258.21 Million JPY | 300.995% |
| H.U. Group Holdings, Inc. | -4.04 Billion JPY | 112.837% |
| FALCO HOLDINGS Co., Ltd. | 2.15 Billion JPY | 75.883% |
| BML, Inc. | 9.16 Billion JPY | 94.339% |
| Human Metabolome Technologies, Inc. | 220.16 Million JPY | -135.729% |
| Precision System Science Co., Ltd. | -956.24 Million JPY | 154.275% |